A Shire Thing?
Acceleron Files IPO For $75M; Celgene Promises to Buy More
By Randy Osborne
Wednesday, August 7, 2013
Three months after Shire plc pulled the plug on their potential $498 million collaboration, Acceleron Pharma Inc. has filed for an initial public offering (IPO) that aims for about $74.7 million, and has extracted from its continuing partner Celgene Corp. a promise to buy more shares in an undisclosed amount at the IPO price, if the deal goes through.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.